Compare ANTX & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANTX | ATCH |
|---|---|---|
| Founded | 2017 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.2M | 34.9M |
| IPO Year | 2022 | 2024 |
| Metric | ANTX | ATCH |
|---|---|---|
| Price | $1.05 | $0.23 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | 65.6K | ★ 4.3M |
| Earning Date | 02-26-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.23 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.14 |
| 52 Week High | $1.49 | $7.25 |
| Indicator | ANTX | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 42.38 |
| Support Level | $1.03 | $0.17 |
| Resistance Level | $1.16 | $0.24 |
| Average True Range (ATR) | 0.06 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 33.33 | 29.70 |
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.